Combination Therapy Approved for Adults With Mesothelioma
Combination immunotherapy that is used to treat patients with malignant melanoma or non –small cell lung cancer has received FDA approval for adults with unresectable malignant pleural mesothelioma.
Source: JAMA - Category: General Medicine Source Type: research
More News: Asbestosis | Cancer | Cancer & Oncology | General Medicine | Immunotherapy | Lung Cancer | Melanoma | Mesothelioma | Skin Cancer